Jump to Footer

Natalia Shcherbakova

Associate Professor of Pharmacoeconomics
Department of Pharmaceutical & Administrative Sciences

Email:     natalia.shcherbakova@wne.edu
Phone:   413-796-2441
Office:    CSP 318


Dr. Shcherbakova’s research interests include real-world population-based studies of medication use outcomes including medication effectiveness, safety, pharmacoeconomics, persistence and adherence with chronic therapies, managed care program evaluation (e.g., outcomes of pharmacist-delivered interventions).  In addition, she is interested in how social media and participatory medicine transform healthcare. Prior to joining Western New England University College of Pharmacy, she had experience working in pharmaceutical and healthcare consulting companies including Novartis Pharma, Biogen Idec and Avalere Health, a health policy consulting agency in Washington D.C.

 

Education

Doctor of Philosophy  - University of Texas at Austin College of Pharmacy, Division of Health Outcomes & Pharmacy Practice, Austin, TX
Master of Science  - University of Texas at Austin College of Pharmacy, Division of Health Outcomes & Pharmacy Practice, Austin, TX
Specialist (Pharmacy) - Perm State Pharmaceutical Academy, Perm, Russia 

Teaching

Pharmacy Outcomes (Pharmacoeconomics) - instructor of record
Healthcare Policy & Delivery- instructor of record
Pharmaceutical Industry in a Global Context (Elective) - instructor of record
Drug Information & Literature Evaluation (Biostatistics content area) – instructor
Independent Study (Social & Administrative Pharmacy Research) - instructor of record
Advanced Pharmacy Practice Experience (Academic Rotation) - preceptor
Healthcare Communications - contributor

Research Affiliations:

Health New England, Inc, Springfield, MA
Institute for Healthcare Delivery and Population Science , University of Massachusetts Medical School- Baystate, Springfield, MA

Research / Scholarship

Dr. Shcherbakova’s research interests include real-world population-based studies of medication use outcomes including medication effectiveness, safety, pharmacoeconomics, persistence and adherence with chronic therapies, managed care program evaluation (e.g., outcomes of pharmacist-delivered interventions).  In addition, she is interested in how social media and participatory medicine transform healthcare. Prior to joining Western New England University College of Pharmacy, she had experience working in pharmaceutical and healthcare consulting companies including Novartis Pharma, Biogen Idec and Avalere Health, a health policy consulting agency in Washington D.C.

Publications (peer-reviewed)

  • Shcherbakova N, Desselle S. Looking back at U.S. Pharmacy’s past to help discern its future. Ann Pharmacother. 2020 (In press; Available at: https://journals.sagepub.com/doi/full/10.1177/1060028020911085 ).
  • Rivera J, Shcherbakova N, Vala C, Capoccia K. Community pharmacists’ interventions and documentation during medication therapy management encounters delivered face-to-face versus via telephone: The devil is in the details. Research in Social & Administrative Pharmacy. 2019; (In-press).
  • Shcherbakova N. Pharmaceutical industry in a global context elective course: implementation and preliminary outcomes. Int J Pharm Pract. 2018;26:465-8; 10.1111/ijpp.12449.
  • Shcherbakova N, Tereso G, Spain J, Roose RJ. Treatment Persistence among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder. Ann Pharmacother. 2018;52:405-14; 10.1177/1060028017751913.
  • Mo Y, Thomas MC, Laskey CS, Shcherbakova N, Bankert ML, Halloran RH. Current Practice Patterns in the Management of Alcohol Withdrawal Syndrome. P T. 2018;43:158-62.
  • Shcherbakova N, Tereso G. Clinical Pharmacist Home Visits and 30-day Readmission in Medicare Advantage Beneficiaries. Journal of Evaluation in Clinical Practice. 2016; 22: 363-368.
  • Robinson E, Shcherbakova N, Backer L. Assessment of Pharmacy Manpower and Services in New England. Journal of Pharmacy Practice. 2016; 29(6):549-555.
  • Shcherbakova N, Rascati K, Brown C, Lawson K, Richards EK, Novak S, Yoder L. Factors Associated with Seizure Recurrence in Epilepsy Patients Treated with Antiepileptic Monotherapy. CNS Drugs. 2014; 28 (11): 1047-1058.
  • Shcherbakova N, Shepherd M. Community Pharmacists, Internet and Social Media: An Empirical Investigation. Research in Social & Administrative Pharmacy. 2013; 10 (6): e75-e85.
  • Shcherbakova N, Shepherd M, Lawson K, Richards K. The Role of Authorized Generics in the Prescription Drug Marketplace. Journal of Generic Medicines. 2011; 8 (1):28-40. (Second most-read article of the journal during August 2011)
  • Gavaza P, Shepherd M, Shcherbakova N, Khoza S. The State of Health Economics and Pharmacoeconomics Research in Russia: A Systematic Review. Journal of Pharmaceutical Health Services Research. September 2010; 1(3):113-121.

Publications (non peer-reviewed)

1) Book Chapter. Kohn C, Shcherbakova N, Montero A. Cost-effectiveness and Financial Toxicity of Cancer Immunotherapies. Society for Immunotherapy of Cancer (SITC’s) Guide to Managing Immunotherapy Toxicity. 2019. ISBN: 9780826172150.

2) Shcherbakova N. The Delivery Mode Matters when Surveying U.S. Practicing Pharmacists: The Reason to Say ‘no’ to the Hybrid. Research in Social & Administrative Pharmacy. 2016; 12 (1): 169-70.

3)Shcherbakova N. Book review: “Let Patients Help! A 'patient engagement' handbook - how nurses, patients and caregivers can partner for better care.” Journal of Participatory Medicine.  August 2013. Available at: http://www.jopm.org/media-watch/books-literature/2013/08/07/book-review-let-patients-help/

 

Conference proceedings (peer-reviewed) 

  • Osmond D, Shcherbakova N, Huston S. Prestige and Versatility: Choosing Pharmacy. American Journal for Pharmaceutical Education 2019; 83(5): 7654.
  • Haong W, Shcherbakova N. Impact of Clinical and Economic Evidence on Cancer Drug Sales. Value in Health. 2019; 22 (S2), S79.
  • Charbonneau M, Harrison K, Shcherbakova N, Capoccia K. Sharps Disposal Practices among People with Diabetes in a Community Care Clinic: Identifying Opportunities for Focused Sharps Disposal Education. Journal of American Pharmacists Association 2019; forthcoming.
  • Shcherbakova N, Tereso G. “If You Break It, They Won’t Come”- Impact of Access Restriction on Use of Short-Acting Prescription Opioids in a US Health Plan. Journal of American Pharmacists Association 2019; forthcoming.
  • Shcherbakova N, Kwarteng S, Obike, P. Web-Presence and Services Offered by Independent Community Pharmacists in Massachusetts. Journal of American Pharmacists Association 2019; forthcoming.
  • Josefiak K, Shcherbakova N, Mattison M. Pharmacists’ and Fourth Year Pharmacy Students’ Intention to Counsel on OTC Products and Knowledge of Counseling Points regarding Several OTC-sensitive Common Conditions including Acne Vulgaris. Journal of American Pharmacists Association 2019; forthcoming.
  • Mo Y, Shcherbakova N, Zeibeq J, Muzykovsky K, Thai P, Li W, Ahmad M, Gasperino J. Clinical and Economic Impact of the Use of Dexmedetomidine for Sedation in the Intensive Care Unit. Critical Care Medicine 2019; 47 (1):436.
  • Shcherbakova N, Tereso G. Impact of Access Restriction on Use of Short-Acting Prescription Opioids in a U.S. Health Plan. Value in Health. 2018; 21 (3), S168.
  • Haong W, Shcherbakova N. Predictors of Monthly Oncology Drug Costs at Launch in the USA, 2009-2016. American Journal for Pharmaceutical Education 2018; 82(5): 7158
  • Haong W, Shcherbakova N. Correlates of Oncology Drug Prices in the U.S. Value in Health. 2018; 21 (S1), S101.
  • Rivera J, Vala C, Mattison M, Capoccia K, Shcherbakova N. Pharmacist Interventions during a Community Pharmacy MTM Encounter: Identifying Opportunities for Improvement of Care and Outcomes. Journal of American Pharmacists Association 2018; 58 (3): e93.
  • Shcherbakova N. Pharmaceutical Industry in a Global Context Elective: Development, Implementation and Outcomes. American Journal of Pharmaceutical Education. 2017; 81(5):S5.
  • Shcherbakova N, Tereso G, Colby A, D’Angelo L. Correlates of twelve week treatment adherence among patients with hepatitis C newly initiating direct acting antiviral therapies including sofosbuvir containing, ledipasvir/sofosbuvir and ombitasvir/paritaprevir/ritonavir -dasabuvir regimens. Value in Health. May 2017; 20:A185.
  • Shcherbakova N, Tereso G. Spain J, Roose R. Predictors of high direct annual healthcare costs among patients with opioid use disorder newly initiating buprenorphine-containing pharmacotherapy. Journal of American Pharmacists Association 2017; 57:e131.
  • Ruban C, Noone JM, Marino J, Shcherbakova N, Saunders W, Blanchette CM.  Examining Corticosteroid-Induced Type 2 Diabetes in the COPD Medicare Population.  Value in Health. May 2016; 19 (3): A110-111.
  • Shcherbakova N, Tereso G. Spain J. Factors associated with treatment persistence among patients newly initiated on opioid substitution pharmacotherapy. Journal of American Pharmacists Association 2016; 5(3):e133.
  • Shcherbakova N, Makhinova T, Silveira K. Factors Associated with Academic Performance among First-year Pharmacy Students. American Journal of Pharmaceutical Education 2015; 79 (5):90-91.
  • Shcherbakova N, Tereso G, Coderre K. Clinical and Humanistic Outcomes of an In-home Clinical Pharmacist Intervention Program. Pharmacotherapy.  June 2014; 34 (6): 15.
  • Shcherbakova N, Robinson E, Backer L. Assessment of Pharmacy Manpower and Services in New England,” 9th Annual New England Pharmacists Convention, Mashantucket, CT (poster presentation); September 19-20, 2013.
  • Aparasu R, West-Strum DS, Patel H, Zuckerman IH, Shcherbakova N, Rasu R, Ersin OH, Best Practices in Building Research Teams for Success in Social and Administrative Sciences. American Journal of Pharmaceutical Education 2013; 77 (5):110.
  • Shcherbakova N, Rascati K, Brown C, Lawson K, Richards EK, Novak S, Yoder L. Acute Care Utilization in Patients with Epilepsy on Antiepileptic Monotherapy. Value in Health. 2013; 16 (3): A100.
  • Shcherbakova N, Barnes J, Roberts R, Wilson J. Assessment of Internet and Social Media Use for Educational Purposes by Third-Year Pharmacy Students. American Journal of Pharmaceutical Education 2012; 76 (5):97.
  • Shcherbakova N, Shepherd M, Makhinova T. Assessment of Internet and Social Network Use by Texas Independent Community Pharmacists. Journal of American Pharmacists Association 2012; 52 (2):272.
  • Gavaza P, Shepherd M, Shcherbakova N, Khoza S. The State of Health Economics and Pharmacoeconomics Research in Russia: A Systematic Review. Value in Health. May 2011; 14 (3):25.
  • Shcherbakova N, Shepherd M, Lawson K, Richards K. The Role of Authorized Generics in the Prescription Drug Marketplace. Abstract published in Value in Health. May 2010; 13(3):100.
  •  

Professional Affiliations

  • American Association of Colleges of Pharmacy (AACP)
  • International Society for Pharmacoepidemiology (ISPE)
  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
  • Rho Chi  Pharmacy Honors Society
  • Society for Participatory Medicine
  • Editorial Board Member,  Research in Social & Administrative Pharmacy

Professional Recognition

Editor recognition for quality peer-reviews/top reviewer

  • Journal of Managed Care and Specialty Pharmacy                         Aug 2018
  • Pharmacoepidemiology and Drug Safety                                        Aug 2016
  • Pharmacoepidemiology and Drug Safety                                        Aug 2015
  • Research in Social & Administrative Pharmacy                              Dec 2015

Professional Service

  • Editor recognition for quality peer-reviews/top reviewer

    • Journal of Managed Care and Specialty Pharmacy                         Aug 2018
    • Pharmacoepidemiology and Drug Safety                                        Aug 2016
    • Pharmacoepidemiology and Drug Safety                                        Aug 2015
    • Research in Social & Administrative Pharmacy                              Dec 2015

Journal reviewer

  • American Journal of Managed Care
  • Annals of Pharmacotherapy
  • BMC Neurology
  • Currents in  Pharmacy Teaching & Learning
  • International Journal of Pharmacy Practice
  • Journal of American Pharmacists Association
  • Journal of Managed Care & Specialty Pharmacy
  • Journal of Medical Internet Research
  • Journal of Mental Health
  • Journal of Participatory Medicine
  • Journal of Patient Experience
  • Journal of Pharmacy Practice
  • Patient Preference and Adherence
  • Pediatric Drugs
  • Pharmacoepidemiology & Drug Safety
  • Research in Social and Administrative Pharmacy
  • Value in Health

Social Media

Twitter: @creativepharma

 

Bibliographic databases